You will find in this section the recent latest new from the ICH.

3 June 2018

ICH Q3D(R1) revision reaches Step 2b of the ICH Process

The ICH Q3D(R1) Revision of the ICH Q3D Guideline for Elemental Impurities reached Step 2b of the ICH Process in May 2018 and now enters the consultation period. The ICH Q3DR1) Revision is focused on an error correction in the...

30 April 2018

The ICH S9 Q&As reaches Step 4 of the ICH Process

The ICH S9 Q&As on Nonclinical Evaluation for Anticancer Pharmaceuticals reached Step 4 of the ICH Process in April 2018 and now enters into the implementation period (Step 5). This new Q&As is proposed to facilitate...

31 January 2018

The ICH Assembly and MC Reports from the Geneva meeting, November 2017, available now on the ICH Website

In November 2017, the ICH Assembly and Management Committee met in Geneva, Switzerland, for their biannual meeting. Main decisions taken at the ICH Assembly meeting are reflected in a report including the key progress made at...

30 November 2017

Press release ICH MedDRA Management Committee meeting in Geneva, Switzerland, November 2017

The MedDRA Management Committee met in Geneva, Switzerland on 11-12 November 2017. Ms. Sophie Sommerer (Health Canada, Canada) was appointed as Chair with the unanimous support of the Committee to serve until November...